Глобальная карта > Инновации > North America and Caribbean > United States > Palo Alto > Gen1E Lifesciences
Gen1E Lifesciences
GEn1E’s p38 kinase inhibitor drugs treats Acute Respiratory Distress Syndrome (ARDS) - 67% of the critically ill COVID-19 patients had ARDS.
Rankings by 
Национальный рейтинг
400th
in United StatesРегиональный рейтинг
455th
in North America and CaribbeanГлобальный рейтинг
1083rd
worldwide